Global Gonorrhea Diagnostics Market 2016-2020

Overview of the global gonorrhea diagnostics market

Technavio’s market research analyst predicts the global gonorrhea diagnostics market to grow at a CAGR of more than 9% by 2020. There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.

The growing use of molecular diagnostics for performing gonorrhea tests is a key trend in this market. Some of the new technologies in molecular diagnostics include PCR-based techniques, nucleic acid amplification tests, and DNA nanotechnology. As a result of the high efficiency, variety, accuracy, and reliability of these gonorrhea tests, the growing use of molecular diagnostics is expected to have a positive impact on the growth of the global gonorrhea diagnostics market during the forecast period.

Segmentation by application and analysis of gonorrhea diagnostics market

• Chromatography
• Diagnostic imaging
• Differential light scattering
• Flow cytometry
• Gel microdroplets
• Immunoassay
• Molecular diagnostics
• Monoclonal antibodies test

The molecular diagnostics procedure involves the nucleic acid extraction mixtures from gonorrhea cultures that act as a template for the diagnosis. The advancement in molecular biology has played a crucial role in the molecular diagnostics technology positively and has helped in developing a rapid and safe assays for diseases like gonorrhea. Nucleic acid amplification test is the most important molecular diagnostic test involved in the gonorrhea diagnosis.

Geographical segmentation and analysis of gonorrhea diagnostics market

• Americas
• APAC
• EMEA

The Americas accounted for 48% share of the gonorrhea diagnostics market during 2015 and is expected to retain its market dominance during the forecast period. The US is the largest revenue contributor for the sales of gonorrhea diagnosis products. Factors such as the high prevalence of gonorrhea disease, shift to molecular diagnostic tests, and increasing FDA approvals for new products will result in this region’s growth during the forecast period.

Competitive landscape and key vendors

This market is highly fragmented and competitive, with the presence of well-diversified international, regional, and local vendors. Local vendors face stiff competition in the market as the international players are increasing their footprints, especially in terms of features and quality. The competition in this market is expected to intensify during the forecast period with an increase in product extensions and technological innovations and an increase in mergers and acquisitions. The lack of skilled laboratory professionals and requirement for high capital investment are major challenges for regional and local players, preventing them from expanding dynamically.

Key vendors in this market are -

• Abbott Laboratories
• Beckman Coulter
• Roche Diagnostics
• Siemens

The other prominent vendors in the gonorrhea diagnostics market are Agilent Technologies, Alere, Becton Dickinson and Company, Bio-Rad, Cepheid, Diamedix, Kyowa Medex, Lonza, Mackay Life Sciences, Nihon Kohden, Ortho-Clinical Diagnostics, Polymedco, Qiagen, SDIX, Sequenom, Sienco, Sysmex, Takara Bio, ThermoFisher.

Key questions answered in the report include

• What will the market size and the growth rate be in 2020?
• What are the key factors driving the global gonorrhea diagnostics market?
• What are the key market trends impacting the growth of the global gonorrhea diagnostics market?
• What are the challenges to market growth?
• Who are the key vendors in the global gonorrhea diagnostics market?
• What are the market opportunities and threats faced by the vendors in the global gonorrhea diagnostics market?
• Trending factors influencing the market shares of the Americas, APAC, and EMEA.
• What are the key outcomes of the five forces analysis of the global gonorrhea diagnostics market?